Spin-Offs
Sanquinnovate is actively looking for venture partners for its existing and new ventures.
For more information about our portfolio please contact our business development team at: partnering@sanquin.nl.
Spin-offs
Alveron Pharma is developing a unique coagulation platform technology with the world's first cyclodextrin-based anticoagulant reversal drug. For more information, see: www.alveron.com.
Innovative new treatment of sepsis by apheresis.
For more information, see: www.sansepsis.com.